Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  2002-08-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(02)09670-8PMID 12241713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Promotion of Collateral Growth by Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Study

  2001cited by this paper
• Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines

  2001cited by this paper
• Augmentation of Postnatal Neovascularization With Autologous Bone Marrow Transplantation

  2001cited by this paper
• Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

  2000cited by this paper
• A role for hematopoietic stem cells in promoting angiogenesis.

  2000cited by this paper
• Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

  2000cited by this paper
• Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC).

  2000cited by this paper
• VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

  2000cited by this paper
• Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.

  2000cited by this paper
• Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.

  1999cited by this paper
• Clinical applications of angiogenic growth factors and their inhibitors

  1999cited by this paper
• Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

  1999cited by this paper
• Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization

  1999cited by this paper
• Interleukin-1βUpregulates Cardiac Expression of Vascular Endothelial Growth Factor and its Receptor KDR/flk-1 via Activation of Protein Tyrosine Kinases

  1999cited by this paper
• Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.

  1999cited by this paper
• Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

  1999cited by this paper
• Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb.

  1998cited by this paper
• Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia.

  1998cited by this paper
• Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues

  1997cited by this paper
• Angina pectoris occurring during granulocyte colony‐stimulating factor‐combined preparatory regimen for autologous peripheral blood stem cell transplantation in a patient with acute myelogenous leukaemia

  1997cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Acute arterial thrombosis due to platelet aggregation in a patient receiving granulocyte colony‐stimulating factor

  1996cited by this paper
• Peripheral blood stem cell collection using the small volume collection chamber in the Fenwal CS-3000 Plus blood cell separator.

  1994cited by this paper
• Second European Consensus Document on chronic critical leg ischemia.

  1991cited by this paper
• Roles of P2‐Purinoceptors in the Cardiovascular System

  1991cited by this paper
• Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization

  1988cited by this paper
• Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

  1987cited by this paper
• Suggested standards for reports dealing with lower extremity ischemia. Prepared by the Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery.

  1986cited by this paper

• Circulating Proteomic Panels for Noninvasive Diagnosis and Prognostication of Thromboangiitis Obliterans.

  2025cites this paper
• A Phase 1/2a Clinical Trial to Evaluate the Efficacy and Safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cell Clusters in Patients with Critical Limb Ischemia

  2025cites this paper
• Young-derived M2-like macrophages ameliorate hindlimb ischemia injury by promoting neovascularization in aged mice.

  2025cites this paper
• Self-assembled hybrid hydrogel microspheres create a bone marrow-mimicking niche for bone regeneration

  2025cites this paper
• Low-Intensity Pulsed Ultrasound in Patients With Atherosclerotic Peripheral Arterial Disease: A Pilot Study and Randomized Double-Blind Placebo-Controlled Trial

  2025cites this paper
• Effectiveness of quality and quantity mononuclear cells for enhancing wound healing in diabetic ischemic limb animal model

  2025cites this paper
• Integrin β2 Plays a Significant Role in Therapeutic Angiogenesis Through Hematopoietic Stem Cell Transplantation

  2025cites this paper
• Administration of Glucose-Encapsulated Liposomes with Sialyl Lewis X on the Surface Improves Stroke Outcomes in Mice

  2025cites this paper
• Stem Cell Therapy in No Option Chronic Limb-threatening Ischemia

  2025cites this paper
• Preconditioning Effects of Neuromuscular Electrical Stimulation in Patients with Symptomatic Peripheral Arterial Disease

  2025cites this paper
• Mitochondrial transfer from adipose-derived regenerative cells contributes therapeutic angiogenesis in a murine hindlimb ischemia model

  2025cites this paper
• Bone Marrow Mononuclear Cell Transplantation Promotes Bone Healing via Gap Junction-Mediated Cell-Cell Interaction.

  2025cites this paper
• Study on the Changes of sVCAM-1 Level and Clinical Diagnostic Value in Patients with Lower Extremity Arteriosclerosis Obliterans

  2025cites this paper
• Research Progress on the Treatment of Diabetic Foot Wounds with Human Autologous Components

  2024cites this paper
• Bioengineering Cell Therapy for Treatment of Peripheral Artery Disease.

  2024cites this paper
• Unraveling the differential mechanisms of revascularization promoted by MSCs & ECFCs from adipose tissue or umbilical cord in a murine model of critical limb-threatening ischemia

  2024cites this paper
• Progress on oxygen-releasing bioactive polymeric scaffolds in tissue engineering and biomedical treatment: A review.

  2024cites this paper
• Therapeutic Angiogenesis and Cardiovascular Disease: A Review.

  2024cites this paper
• Narrative Review of CTO Composition to Develop Biomimetic Models of Chronic Limb-Threatening Ischemia to Enhance Revascularization Strategies

  2024cites this paper
• Arterial Leg Ulcers in the Octogenarian.

  2024cites this paper
• Targeting TXNIP in endothelial progenitors mitigates IL-8-induced neutrophil recruitment under metabolic stress

  2024cites this paper
• Clinical state and future directions of stem cell therapy in stroke rehabilitation.

  2024cites this paper
• Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells

  2024cites this paper
• The effect of bone marrow derived cell therapies on hind limb perfusion, A systematic review and meta-analysis.

  2024cites this paper
• Human Cord Blood Endothelial Progenitor Cells and Pregnancy Complications (Preeclampsia, Gestational Diabetes Mellitus, and Fetal Growth Restriction)

  2024cites this paper
• Bone marrow cells contribute to seven different endothelial cell populations in the heart

  2024cites this paper
• Combination of melatonin-delivered endothelial progenitor cells with S-nitroso-N-acetyl-DL-penicillamine for improving critical limb ischemia in the rat.

  2024cites this paper
• Effect of Multiple-Cycle Collections of Conditioned Media from Different Cell Sources towards Fibroblasts in In Vitro Wound Healing Model

  2024cites this paper
• Regenerative medicine in cardiovascular disease

  2024cites this paper
• Assessment of Ketamine's Influence on In Vitro Angiogenesis.

  2024cites this paper
• Acupoint transplantation versus non-acupoint transplantation using autologous peripheral blood mononuclear cells in treating peripheral arterial disease

  2024cites this paper
• Translational Relevance of Advanced Age and Atherosclerosis in Preclinical Trials of Biotherapies for Peripheral Artery Disease

  2024cites this paper
• Effects of human amniotic membrane on the angiogenesis and healing of ischemic wounds in a rat model

  2024cites this paper
• Facing the Challenges of Peripheral Arterial Disease in the Era of Emerging Technologies

  2024cites this paper
• The comparison of adipose-derived stromal cells (ADSCs) delivery method in a murine model of hindlimb ischemia

  2024cites this paper
• Therapeutic angiogenesis for patients with chronic limb-threatening ischemia: promising or hoax?

  2024cites this paper
• Application of Pro-angiogenic Biomaterials in Myocardial Infarction

  2024cites this paper
• Low-intensity pulsed ultrasound improves symptoms in patients with Buerger disease: a double-blinded, randomized, and placebo-controlled study

  2024cites this paper
• Current Advances and Challenges in Stem Cell-Based Regenerative Therapy for Chronic Limb-Threatening Ischemia

  2024cites this paper
• Autologous Bone Marrow Stem Cells in Patients With Critical Limb Ischaemia not Eligible for Revascularization: A Single Centre Experience

  2023cites this paper
• Stem Cell Therapy in Critical Limb Ischemia

  2023influential citation
• Exploring the Effects of Human Bone Marrow-Derived Mononuclear Cells on Angiogenesis In Vitro

  2023influential citation
• Novel Vascular Roles of Human Endoglin in Pathophysiology.

  2023cites this paper
• The Effects of Immunosuppressive Drugs on the Characteristics and Functional Properties of Bone Marrow-Derived Stem Cells Isolated from Patients with Diabetes Mellitus and Peripheral Arterial Disease

  2023cites this paper
• Cell Therapy of Severe Ischemia in People with Diabetic Foot Ulcers—Do We Have Enough Evidence?

  2023cites this paper
• CD34 positive cells as endothelial progenitor cells in biology and medicine

  2023cites this paper
• Modalities to Deliver Cell Therapy for Treatment of Chronic Limb Threatening Ischemia

  2023cites this paper
• Autologous angiogenic therapy with cultured mesenchymal stromal cells in platelet-rich plasma for critical limb ischemia

  2023cites this paper
• Peripheral arterial disease (PAD) - A challenging manifestation of atherosclerosis.

  2023cites this paper
• Recent advances in the immunomodulation mechanism of mesenchymal stem cell therapy in liver diseases

  2023cites this paper
• ABCB5+ mesenchymal stromal cells therapy protects from hypoxia by restoring Ca2+ homeostasis in vitro and in vivo

  2023cites this paper
• A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans.

  2023cites this paper
• Mesenchymal stem cell-based therapy for non-healing wounds due to chronic limb-threatening ischemia: A review of preclinical and clinical studies

  2023cites this paper
• Characterization of the microenvironment of diabetic foot ulcers and potential drug identification based on scRNA-seq

  2023cites this paper
• Function and mechanism of mesenchymal stem cells in the healing of diabetic foot wounds

  2023cites this paper
• Mesenchymal Stem/Stromal Cells in Skeletal Muscle Are Pro-Angiogenic, and the Effect Is Potentiated by Erythropoietin

  2023cites this paper
• Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?

  2023cites this paper
• Stem Cell Therapy: A Possible Role in the Treatment of Patients with Chronic Limb-Threatening Ischemia?

  2023cites this paper
• The quality and quantity media-cultured mononuclear cell transplantation is safe and effective in ischemic hindlimb mouse model

  2023cites this paper
• Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI)

  2023cites this paper
• Injectable microcapillary network hydrogels engineered by liquid-liquid phase separation for stem cell transplantation

  2023cites this paper
• Mesenchymal Stem/Stromal Cells for Therapeutic Angiogenesis

  2023cites this paper
• Prognostic Value of Endothelial Progenitor Cells in Acute Myocardial Infarction Patients

  2023cites this paper
• Smoking and Diabetes Attenuate Number of CD34+ Haematopoietic Stem Cells in Peripheral Blood of Patients with Advanced Peripheral Artery Disease

  2023cites this paper
• Knowledge Mapping of Global Status and Trends for Thromboangiitis Obliterans: A Bibliometrics and Visual Analysis

  2023cites this paper
• Therapeutic Angiogenesis for Thromboangiitis Obliterans.

  2023cites this paper
• Therapeutic angiogenesis in Buerger’s disease: reviewing the treatment landscape

  2022cites this paper
• A combined cell and growth factor delivery for the repair of a critical size tibia defect using biodegradable hydrogel implants

  2022cites this paper
• Efficient generation of endothelial cells from induced pluripotent stem cells derived from a patient with peripheral arterial disease

  2022cites this paper
• Current State and Issues of Regenerative Medicine for Rheumatic Diseases

  2022cites this paper
• Combinational stem cell therapy for critical hindlimb ischemia using dental pulp stem cells and human umbilical vein endothelial cells.

  2022cites this paper
• Long-term Results of Surgical Treatment and Cell Therapy in Patients with Type 2 Diabetes and Chronic Lower Limb Ischemia

  2022cites this paper
• Effect of MNCQQ Cells on Migration of Human Dermal Fibroblast in Diabetic Condition

  2022cites this paper
• Cellular therapies in no-option critical limb ischemia: present status and future directions

  2022cites this paper
• Small extracellular vesicles of hypoxic endothelial cells regulate the therapeutic potential of adipose-derived mesenchymal stem cells via miR-486-5p/PTEN in a limb ischemia model

  2022cites this paper
• Biomimetic virus-based soft niche for ischemic diseases.

  2022cites this paper
• Metformin pre-treatment of stem cells from human exfoliated deciduous teeth promotes migration and angiogenesis of human umbilical vein endothelial cells for tissue engineering.

  2022cites this paper
• CCL2 promotes proliferation, migration and angiogenesis through the MAPK/ERK1/2/MMP9, PI3K/AKT, Wnt/β‑catenin signaling pathways in HUVECs

  2022cites this paper
• Restoration of vascular endothelial integrity by mesenchymal stromal/stem cells in debilitating virus diseases

  2022cites this paper
• Therapeutic angiogenesis for patients with no-option critical limb ischemia by adipose-derived regenerative cells: TACT-ADRC multicenter trial

  2022influential citation
• AAV-mediated expression of PFKFB3 in myofibers, but not endothelial cells, improves ischemic muscle function in mice with critical limb ischemia.

  2022cites this paper
• International Union of Angiology (IUA) position statement on no-option chronic limb threatening ischemia.

  2022cites this paper
• Combination stem cell therapy using dental pulp stem cells and human umbilical vein endothelial cells for critical hindlimb ischemia

  2022cites this paper
• Therapeutic angiogenesis-based strategy for peripheral artery disease

  2022cites this paper
• Stem Cell-Based Therapy: A Promising Treatment for Diabetic Foot Ulcer

  2022cites this paper
• A SYSTEMATIC REVIEW AND META-ANALYSIS OF EARLY AND LATE OUTCOMES AFTER ENDOVASCULAR ANGIOPLASTY AMONG PATIENTS WITH THROMBOANGIITIS OBLITERANS AND CHRONIC LIMB ISCHEMIA.

  2022cites this paper
• Local intramuscular transplantation of autologous bone marrow mononuclear cells for critical lower limb ischaemia.

  2022cites this paper
• Stem Cell Therapy in Limb Ischemia: State-of-Art, Perspective, and Possible Impacts of Endometrial-Derived Stem Cells

  2022cites this paper
• Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review

  2022cites this paper
• ROLE OF STEM CELLS IN TREATMENT OF UNCORRECTABLE CRITICAL LOWER LIMB ISCHAEMIA IN DIABETIC PATIENTS

  2022cites this paper
• Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia

  2022cites this paper
• Research Progress in Dressing Selection for Diabetic Wound Healing

  2022cites this paper
• Stem and Somatic Cell Monotherapy for the Treatment of Diabetic Foot Ulcers: Review of Clinical Studies and Mechanisms of Action

  2022cites this paper
• PBMNCs Treatment in Critical Limb Ischemia and Candidate Biomarkers of Efficacy

  2022cites this paper
• Implantation of Hypoxia-Induced Mesenchymal Stem Cell Advances Therapeutic Angiogenesis

  2022cites this paper
• The role of exercise-induced myokines in promoting angiogenesis

  2022cites this paper
• Immunological response of polysaccharide nanogel-incorporating PEG hydrogels in an in vivo diabetic model

  2022cites this paper
• Ex vivo conditioning of peripheral blood mononuclear cells of diabetic patients promotes vasculogenic wound healing

  2021cites this paper
• Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy

  2021cites this paper
• Overcoming ischemia in the diabetic foot: Minimally invasive treatment options

  2021cites this paper